Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...

But if your legs ache every time you walk, it could be peripheral artery disease (PAD). Here we break down what the condition ...

Paclitaxel-coated balloons and paclitaxel-eluting stents should be withheld from routine use in patients with intermittent claudication until further evidence on their safety profile is available, an ...

Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease. We ...

Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...

MADRID -- Paclitaxel coating added no benefit to balloons and stents for endovascular peripheral arterial disease (PAD) intervention in the SWEDEPAD 1 and 2 trials -- and in fact, researchers said ...